Bruton's agammaglobulinemia

Also known as: X-Linked Agammaglobulinemia / X-linked Agammaglobulinaemia / Bruton's agammaglobulinaemia / Congenital agammaglobulinemia / Congenital agammaglobulinaemia

DrugDrug NameDrug Description
DB00028Immune Globulin HumanIntravenous immunoglobulin (IVIg) is a mixture of IgG1 and other antibodies derived from healthy human plasma via Cohn fractionation. The purification process includes cold alcohol fractionation, polyethylene glycol precipitation, and ion exchange chromatography. IVIg contains the same distribution of IgG antibody subclasses as is found in the general human population. IgG subclasses are fully represented in the following proportions: 70.3% IgG1, 24.7% IgG2, 3.1% IgG3, and 1.9% IgG4. IVIg is used in the treatment of immunodeficiencies, as well as autoimmune and inflammatory disorders.
DrugDrug NamePhaseStatusCount
DB00087Alemtuzumab2Recruiting1
DB01073Fludarabine2Recruiting1
DB01042Melphalan2Recruiting1
DB04572Thiotepa2Recruiting1
DB00028Immune Globulin Human3Completed2
DB00028Immune Globulin Human4Completed1
DB01008BusulfanNot AvailableTerminated1
DB00091CiclosporinNot AvailableTerminated1
DB00531CyclophosphamideNot AvailableTerminated1
DB00773EtoposideNot AvailableTerminated1
DB00563MethotrexateNot AvailableTerminated1
DB00959MethylprednisoloneNot AvailableTerminated1
DB00635PrednisoneNot AvailableTerminated1
DB10318Varicella Zoster Vaccine (Live/Attenuated)Not AvailableRecruiting1